Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Gender identity services: GPhC publishes new resource for pharmacy professionals

Gender identity services: GPhC publishes new resource for pharmacy professionals

The regulatory body sets out questions that pharmacy professionals should ask themselves when providing gender identity care 

The General Pharmaceutical Council (GPhC) has produced a new resource to support pharmacists and pharmacy technicians who are providing pharmacy services to children and young people with gender incongruence or dysphoria.


It emphasises that pharmacy teams providing such services need to adhere to the standard process of clinical assessment and care provision they have been trained to take as healthcare professionals.

The starting point is that pharmacy professionals must provide compassionate, inclusive and person-centred care, within the current relevant legal and regulatory context.

“It’s essential that all patients have access to appropriate, high-quality and respectful healthcare, free from discrimination or bias,” the GPhC noted.

The GPhC observed that recent developments, such as the release of the final Cass report and various national policy updates, have raised complex questions for pharmacy professionals about prescriptions for puberty suppressing hormones, cross-sex hormones and related medicines for children and young people.

Although pharmacists are not expected to be prescribing in this context, the regulatory body recognises that there may be challenges and questions associated with the supply of medicines.

Earlier, the GPhC set out several issues to consider when providing any services to children and young people presenting with gender identity issues.

This time, it has outlined the associated questions that pharmacy professionals should consider when making decisions about the supply of medicines in this context, applicable to both in-person and online service provisions.

NHS England has commissioned an independent review, led by Dr Hilary Cass, to examine assessment, diagnosis, and care provision for children and young people presenting with gender identity issues. The review, currently underway, aims to offer guidance for the future of services in England.

More For You

Henry Gregg, new Chief Executive of the National Pharmacy Association.
Henry Gregg
Henry Gregg

Community pharmacy voices need to be ‘heard really loud’, new NPA chief tells Pharmacy Business

Henry Gregg, the new chief executive of the National Pharmacy Association (NPA), believes community pharmacies have a right to have insight into discussions relating to the pharmacy funding contract.

Currently, Community Pharmacy England (CPE) solely negotiates the elements of the Community Pharmacy Contractual Framework (CPCF) with the Department of Health and Social Care (DHSC) and NHS England.

Keep ReadingShow less
Patient care

The NHS said the benefits were "too small to justify the additional cost"

NHS rejects Alzheimer's drugs shown to delay early-stage of disease

Two new treatments for Alzheimer's disease will not be offered on the NHS due to high costs and "too small" benefits.

Donanemab and Lecanemab have been hailed as breakthrough treatments for slowing down the symptoms of early-stage Alzheimer's, the most common type of dementia.

Keep ReadingShow less
Air pollution in UK linked to thousands of deaths and chronic health conditions

A report by the Royal College of Physicians claims that air pollution was causing harm to almost every organ of the body.

iStock

Royal College of Physicians paints grim picture of air pollution in UK

Doctors warn that around 99 per cent of the population in the UK are breathing "toxic air", and around 30,000 deaths will be linked to air pollution in 2025.

The Royal College of Physicians (RCP) claimed in a report that air pollution was causing harm to almost every organ of the body, and shortening life by 1.8 years on average.

Keep ReadingShow less
Community pharmacies falling behind on data security toolkit submissions

The last date for submission is 30 June 2025.

Pic credit: iStock

Community pharmacies falling behind on data security toolkit submissions

More than 50 per cent of the community pharmacies in England have failed to complete their Data Security and Protection Toolkit 2025 with the deadline in less than two weeks.

Necessary guidance regarding the toolkit has previously been provided by Community Pharmacy England (CPE) earlier.

Keep ReadingShow less
Digital guide launched to help patients with osteoporosis

In the UK, over three million people have osteoporosis.

Pic credit: iStock

Digital guide launched to help patients with osteoporosis

The Royal Osteoporosis Society (ROS) has launched a free online service called BoneMed which is aimed to support patients with osteoporosis in taking their medicine and remove barriers to adherence.

After completing a five-minute online survey, patients will be emailed a summary of the medicine they have been prescribed and six further updates throughout the year on their medication.

Keep ReadingShow less